Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer
Fierce Pharma
Tue, 05/30/23 - 11:27 am
Sun Pharma
M&A
Taro Pharmaceuticals
India
Boston Sci Scraps Majority Stake Deal with M.I. Tech
Medical Devices and Diagnostics Industry
Mon, 05/29/23 - 12:07 pm
Medtech
Boston Scientific
M&A
MI Tech
Medtronic Is Sweet on EOFlow
Medical Devices and Diagnostics Industry
Thu, 05/25/23 - 12:46 pm
Medtronic
diabetes
Medtech
M&A
EOFlow
Purdue Pharma to sell consumer business for $397 mln
Reuters
Wed, 05/24/23 - 06:49 pm
Purdue Pharma
M&A
consumer health
Arcardia Consumer Healthcare
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wed, 05/24/23 - 11:18 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A
Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea
Fierce Biotech
Mon, 05/22/23 - 09:58 pm
Concerta Biosciences
Atea Pharmaceuticals
M&A
COVID-19
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Mon, 05/22/23 - 11:40 am
Pfizer
debt
Seagen
M&A
Ironwood to buy VectivBio for $1.15 billion to boost digestive disorder drugs portfolio
Yahoo/Reuters
Mon, 05/22/23 - 10:27 am
Ironwood Pharmaceuticals
VectivBio
M&A
digestive disorders
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Thu, 05/18/23 - 08:42 pm
Horizon Therapeutics
M&A
Amgen
FTC
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Tue, 05/16/23 - 11:02 pm
Amgen
Horizon Therapeutics
M&A
FTC
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Tue, 05/16/23 - 12:17 pm
Amgen
Horizon Therapeutics
FTC
M&A
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Mon, 05/15/23 - 11:19 am
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
A struggling biotech wraps its main assets into a new drug company
BioPharma Dive
Mon, 05/15/23 - 10:01 am
Cyclerion
M&A
Sobi agrees to buy CTI BioPharma for $1.7bn
Pharmaceutical Technology
Thu, 05/11/23 - 09:50 am
Sobi
CTI BioPharma
M&A
hematology
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
antibody-drug conjugate
Merck
Seagen
M&A
AstraZeneca
BioNTech
Bristol Myers Squibb
Magenta agrees to reverse merger with Dianthus after setbacks
BioPharma Dive
Wed, 05/3/23 - 10:48 pm
Magenta Therapeutics
M&A
Dianthus Therapeutics
autoimmune disease
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »